Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 23, 2024, titled "Zydus to acquire 50% stake in Sterling Biotech from Perfect Day to enter intofermentaon-based protein business".
Press Release Aug 23 2024
Filed with NSE · · 4 pages · English
Summary by 6ix AI
This joint venture will focus on manufacturing animal-free protein products to meet global demand and reduce environmental impact. The partnership aims to leverage both companies' strengths to enhance production capabilities and promote sustainable nutrition. Dr. Sharvil Patel, Managing Director of Zydus, emphasized the commitment to growth through strategic collaborations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Zydus Lifesciences Limited on 6ix
In the deck
Earlier from Zydus Lifesciences
- Press Release Aug 09 2024
- Press Release Jul 31 2024
- Press Release Jul 23 2024
- Press Release Jul 22 2024
- Press Release Jul 19 2024
Later from Zydus Lifesciences
- Press Release Aug 27 2024
- Press Release Aug 30 2024
- Zydus receives final approval from USFDA for Scopolamine Transdermal System 1 mg/3 days
- Press Release Sep 10 2024
- Press Release Sep 13 2024
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences